Two of the biggest challenges sponsors face when it comes to clinical trials are bringing down the cost of studies and patient recruitment/retention. One aspect of trials that truly has the potential to impact both is the latest advances in technology. The Internet, social media, electronic data collection, and mobile technologies can reduce the time, effort, and cost of gathering data and significantly improve the experience for trial participants.
Unfortunately, the pharma industry is not known for its rapid acceptance of new technologies. Even technologies that are proven to work and are given the green light by the FDA can be slow to make their way into sponsor firms. We pulled together four pharma executives with a strong background in data and technology to get their thoughts on where we stand with technology adoption, and what new advancements have the best potential to transform the way we conduct trials. The participants in our roundtable are: